Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Economic assessment of platelet glycoprotein iib/iiia receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization - results from the epilog randomized trial

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Lincoff, A. M.
  • Mark, D. B.
  • Tcheng, J. E.
  • Califf, R. M.
  • Bala, M. V.
  • Anderson, K. M.
  • Davidson-Ray, L.
  • Knight, J. D.
  • Cabot, C. F.
  • Topol, Eric
  • Investigators, Epilog

publication date

  • December 2000

journal

  • Circulation  Journal

subject areas

  • Aged
  • Antibodies, Monoclonal
  • Drug Therapy, Combination
  • Health Care Costs
  • Hemorrhage
  • Heparin
  • Humans
  • Immunoglobulin Fab Fragments
  • Middle Aged
  • Myocardial Ischemia
  • Myocardial Revascularization
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIb-IX Complex
  • Platelet Membrane Glycoproteins
  • Postoperative Complications
  • Prospective Studies
  • Treatment Outcome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

PubMed ID

  • 11113041
scroll to property group menus

Additional Document Info

start page

  • 2923

end page

  • 2929

volume

  • 102

issue

  • 24

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support